New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
16:02 EDTSGNTSagent Pharmaceuticals launches Flumazenil Injection
Sagent Pharmaceuticals announced the launch of Flumazenil Injection, USP, a benzodiazepine antagonist, in two latex-free vial presentations. According to IMS for the 12 months ending September 2012, the US market for Flumazenil Injection, USP approximated $5.6M. As with all products in Sagent's portfolio, Flumazenil features the company's PreventIV Measures(SM) packaging and labeling, designed to help reduce medication errors.
News For SGNT From The Last 14 Days
Check below for free stories on SGNT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
10:02 EDTSGNTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:34 EDTSGNTSagent Pharmaceuticals downgraded to Hold from Buy at Needham
Subscribe for More Information
July 30, 2014
07:08 EDTSGNTSagent Pharmaceuticals narrows revenue guidance to upper end of $270M-$290M
Subscribe for More Information
07:07 EDTSGNTSagent Pharmaceuticals reports Q2 EPS 9c, consensus (1c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use